期刊文献+

时辰化疗与传统静脉点滴化疗治疗非小细胞肺癌毒副反应的对比 被引量:1

下载PDF
导出
摘要 目的:探讨时辰化疗与传统静脉点滴化疗治疗非小细胞肺癌毒副反应的对比。方法:非小细胞肺癌患者80例随机分组为治疗组(时辰组)、对照组(传统静脉点滴化疗),两组均使用TP(紫杉醇+顺铂)方案化疗。结果:时辰组恶心呕吐发生率10%,对照组50%例,其他无明显差异。结论:时辰给药在控制顺铂的胃肠道反应方面具有显著性优势,从而提高患者生存质量,值得临床进一步推广使用。
作者 刘慧君
出处 《求医问药(下半月刊)》 2012年第3期570-570,共1页 Seek Medical and Ask The Medicine
  • 相关文献

参考文献8

  • 1Mormont Mc,Levi F. Cancer chronotherapy:principles,applications,And perspectives[J].Cancer,2003,(01):155-169.
  • 2levi F. Cancer chronotherapy[J].Journal of Pharmacy and Pharmacology,1999,(08):891-898.doi:10.1211/0022357991773302.
  • 3郭灵,林焕新,冼励坚.恶性肿瘤时辰化疗的基础理论及实践[J].中国肿瘤临床,2004,31(1):56-59. 被引量:33
  • 4Baker DE. Application of chronotherapy to the treatment of cancer:can changing the timing of drug administration influence efficacy and toxicity[J].Advances in Pharmacy,2004,(03):222228.
  • 5Ohdo S. Changes in toxicity and effectiveness with timing of drug administration implications for drug safety[J].Drug Safety,2003,(14):9991010.doi:10.2165/00002018-200326140-00002.
  • 6Levi F. From circadian rythms to cancer chronotherapeutics[J].Chronobiology International,2002,(01):119.doi:10.1081/CBI-120002676.
  • 7Pugliese P,Garufi C,Perrone M. Quality of life and chronotherapy[J].Chronobiology International,2002,(01):299312.doi:10.1081/CBI-120002605.
  • 8Lis CG,Wood P,You M. Circadian timing in cancer treatment:the biological foundation for an integrative approach[J].Integrative Cancer Therapies,2003,(02):105111.doi:10.1177/1534735403002002002.

二级参考文献24

  • 1[1]Dunlap J C. Molecular Base for Circadian Clock[J]. Cell,1999,96(2): 271~290
  • 2[2]Hrushesky WJM, Bjarnaso GA. Circadian Cancer Therapy[J].J Clin Oncol, 1993, 11(7): 1403~1417
  • 3[3]Lévi F. Circadian Chronotherapy for Human Cancers [J].Lancet Oncol, 2001, 2(5): 307~315
  • 4[4]Lévi F. Chronopharmacology of anticancer agents. In: Redfern PH, Lemmer B, eds. Physiology and pharmacology of biological rhythm[M]. Berlin: Springer-Verlag. 1997, 299~311
  • 5[5]Granda TG, Lévi F. Tumor Based Rhythms of Anticancer Efficacy in Experimenral Models[J]. Chronobiol Int, 2002, 19(1):21~41
  • 6[6]Granda TG, Filipski E, D'Attino RM, et al. Experimental Chronotherapy of Mouse Mammary Adenocarcinoma MA13/C with docetaxel and Doxorubicine as Single Agent and in Combination[J]. Cancer Res, 2001, 61(5): 1996~2001
  • 7[7]Smaaland R, Sothern R B, Laerum O D, et al. Rhythm in Human Bone Marrow and Blood Cells [J]. Chronobiol Int,2002, 19(1): 101~127
  • 8[8]Bjarnason GA, Jodan R. Rhythm in Human gastrointestinal Mucosa and Skin[J]. Chronobiol Int, 2002, 19(1): 129~140
  • 9[9]Harris BE, Song R, Soong SJ, et al. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil level: evidence for circadian variation of plasma drug level in cancer patients receiving 5-fluorouracil by protracted continuous infusion[J]. Cancer Res, 1990, 50(1): 197~201
  • 10[10]Petit E, Milano G, Lévi F, et al. Circadian Varying Plasma Concentration of 5-Fluorouracil During 5-Day Continuous Venous Infusion at Constant Rate in Cancer Patients[J]. Cancer Res, 1988, 48(6): 1676~1679

共引文献32

同被引文献29

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部